![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07K 16/28 | (2006.01) |
A61K 39/395 | (2006.01) | ||
G01N 33/569 | (2006.01) | ||
C12N 5/00 | (2006.01) | ||
G01N 33/577 | (2006.01) | ||
G01N 33/566 | (2006.01) | ||
G01N 33/68 | (2006.01) | ||
A61P 37/00 | (2006.01) | ||
A61K 39/00 | (2006.01) |
(11) | Number of the document | 2913343 |
(13) | Kind of document | T |
(96) | European patent application number | 14186905.7 |
Date of filing the European patent application | 2006-12-20 | |
(97) | Date of publication of the European application | 2015-09-02 |
(45) | Date of publication and mention of the grant of the patent | 2018-08-08 |
(46) | Date of publication of the claims translation | 2018-11-26 |
(30) | Number | Date | Country code |
2005366465 | 2005-12-20 | JP |
(72) |
Kamogawa, Yumiko, JP
Cho, Minkwon, JP
Arai, Naoko, JP
Ishida, Koji, JP
|
(73) |
SBI Biotech Co., Ltd.,
1-6-1, Roppongi, Minato-ku Tokyo 106-6018,
JP
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Anti-ILT7 antikūnas |
Anti-ILT7 antibody |
Payment date | Validity (years) | Amount | |
2024-11-21 | 19 | 347.00 EUR |
2025-12-20 |